Healthtech Investors & VC Firms in United States

2067 firms in this list, with a median first check of $500K. 520 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AL ALIVE Israel HealthTech Fund ASDKMHRB10 people	88🔒	Savyon	IL	Seed–Late Stage	—	+ Add to CRM
ES Esplanade Ventures SESMESAN11 people · Leads rounds	88🔒	Toronto	CA	Pre-Seed–Series B	—	+ Add to CRM
SA sandstorm.vc CSDRFFJN5 people · Leads rounds	88🔒	Dubai	AE	Pre-Seed–Series A	$50K – $500K	+ Add to CRM
AN Angelini Ventures ESPDRHTD4 people	88🔒	Rome	IT	Seed–Growth	—	+ Add to CRM
CR Criteria Bio Ventures PCACSCSC7 people · Leads rounds	88🔒	Barcelona	ES	Seed–Late Stage	—	+ Add to CRM
EL Elysia Capital SBFMFBLA6 people	88🔒	Turin	IT	—	—	+ Add to CRM
IN InHealth Ventures IBBELBRB5 people · Leads rounds	88🔒	London	GB	Pre-Seed–Series A	$500K – $3M	+ Add to CRM
AN ANRI ASJKSNTM4 people · Follows rounds	88🔒	Tokyo	JP	Pre-Seed–Growth	$497K – $78M	+ Add to CRM
AL Altered Capital MTFTLMMF12 people · Leads rounds	88🔒	Auckland	NZ	Series A–Late Stage	—	+ Add to CRM
SM Smilegate Investment HCIPKSYK11 people	88🔒	Seoul	KR	Seed–Growth	$694K – $35M	+ Add to CRM
IG Ignite House of Innovation AYJA2 people · Leads rounds	88🔒	Manila	PH	Pre-Seed–Seed	$90K – $180K	+ Add to CRM
20 2080 Ventures TP1 person · Leads rounds	88🔒	—		Pre-Seed–Growth	$100K – $500K	+ Add to CRM
NO Novalis Biotech JVWVBRCB7 people	88🔒	Ghent	BE	Pre-Seed–Series A	—	+ Add to CRM
PM PM Equity Partner DSSIWMAG10 people	88🔒	Lausanne	CH	Series A–Growth	$2M – $50M	+ Add to CRM
SE SEEDS Capital Follows rounds	88🔒	Singapore	SG	Pre-Seed–Series B	$250K – $9M	+ Add to CRM
PA Pace Ventures MSKGGMLN4 people · Leads rounds	88🔒	Berlin	DE	Pre-Seed–Series A	$550K – $1.6M	+ Add to CRM
SE Sectoral Asset Management FBGDORMS9 people	88🔒	Montreal	CA	Series A–Late Stage	—	+ Add to CRM
AR Artem Ventures LZNSTOGK4 people	88🔒	Selangor	MY	Pre-Seed–Series A	$34K – $2.3M	+ Add to CRM
PO Positive Ventures FKMMASBC12 people	88🔒	São Paulo	BR	Pre-Seed–Series A	—	+ Add to CRM
NA naturalX Health Ventures MACPSBYC5 people · Leads rounds	88🔒	Karlsruhe	DE	Seed–Late Stage	$3.2M – $5.4M	+ Add to CRM
WA WakeUp Capital FWMPAPMW8 people	88🔒	Dublin	IE	Pre-Seed–Series A	—	+ Add to CRM
QU Qubit Health Capital JNPRGKMH10 people	88🔒	London	GB	—	—	+ Add to CRM
MA Matrix Partners China XLDSDZHM6 people · Leads rounds	88🔒	Beijing	CN	Seed–Late Stage	$1.6M – $113M	+ Add to CRM
NE Newtown Partners LCVLLT3 people	88🔒	Cape Town	ZA	Seed–Growth	—	+ Add to CRM

ALIVE Israel HealthTech Fund

SavyonSeed–Late Stage

ASDKMHRB10 people

Esplanade Ventures

TorontoPre-Seed–Series B

SESMESAN11 people

sandstorm.vc

DubaiPre-Seed–Series A$50K – $500K

CSDRFFJN5 people

Angelini Ventures

RomeSeed–Growth

ESPDRHTD4 people

Criteria Bio Ventures

BarcelonaSeed–Late Stage

PCACSCSC7 people

Elysia Capital

Turin

SBFMFBLA6 people

InHealth Ventures

LondonPre-Seed–Series A$500K – $3M

IBBELBRB5 people

ANRI

TokyoPre-Seed–Growth$497K – $78M

ASJKSNTM4 people

Altered Capital

AucklandSeries A–Late Stage

MTFTLMMF12 people

Smilegate Investment

SeoulSeed–Growth$694K – $35M

HCIPKSYK11 people

Ignite House of Innovation

ManilaPre-Seed–Seed$90K – $180K

AYJA2 people

2080 Ventures

Pre-Seed–Growth$100K – $500K

TP1 person

Novalis Biotech

GhentPre-Seed–Series A

JVWVBRCB7 people

PM Equity Partner

LausanneSeries A–Growth$2M – $50M

DSSIWMAG10 people

SEEDS Capital

SingaporePre-Seed–Series B$250K – $9M

Pace Ventures

BerlinPre-Seed–Series A$550K – $1.6M

MSKGGMLN4 people

Sectoral Asset Management

MontrealSeries A–Late Stage

FBGDORMS9 people

Artem Ventures

SelangorPre-Seed–Series A$34K – $2.3M

LZNSTOGK4 people

Positive Ventures

São PauloPre-Seed–Series A

FKMMASBC12 people

naturalX Health Ventures

KarlsruheSeed–Late Stage$3.2M – $5.4M

MACPSBYC5 people

WakeUp Capital

DublinPre-Seed–Series A

FWMPAPMW8 people

Qubit Health Capital

London

JNPRGKMH10 people

Matrix Partners China

BeijingSeed–Late Stage$1.6M – $113M

XLDSDZHM6 people

Newtown Partners

Cape TownSeed–Growth

LCVLLT3 people

Data sourced from public filings and firms' own websites — see our methodology.